← FDA Drug Approvals (Drugs@FDA)

VIVACAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SEPTODONT · Approved 2006-09-27

Drug application

FDA Application #

ANDA077250

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIVACAINE

Generic name

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Active ingredients

BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SEPTODONT

Manufacturer

Septodont, Inc.

First approval

2006-09-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown